Universal Health Services (UHS) Financials

$184.51 +6.32 (+3.55%)

Closing price 03:59 PM Eastern

Extended Trading

$185.18 +0.67 (+0.36%)

As of 07:23 PM Eastern

Annual Income Statements for Universal Health Services

This table shows Universal Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	681	702	752	780	815	944	992	676	718	1,142
Consolidated Net Income / (Loss)	751	747	771	798	828	953	988	657	719	1,163
Net Income / (Loss) Continuing Operations	751	747	771	798	828	953	988	657	719	1,163
Total Pre-Tax Income	1,146	1,156	1,135	1,035	1,066	1,252	1,293	866	940	1,498
Total Operating Income	1,259	1,281	1,280	1,175	1,216	1,358	1,363	1,004	1,175	1,682
Total Gross Profit	4,831	5,181	5,429	5,518	5,789	5,946	6,478	6,637	7,174	8,309
Total Revenue	9,043	9,766	10,410	10,772	11,378	11,559	12,642	13,399	14,282	15,828
Operating Revenue	9,043	9,766	10,410	10,772	11,378	11,559	12,642	13,399	14,282	15,828
Total Cost of Revenue	4,212	4,586	4,981	5,255	5,589	5,613	6,164	6,762	7,107	7,519
Operating Cost of Revenue	4,212	4,586	4,981	5,255	5,589	5,613	6,164	6,762	7,107	7,519
Total Operating Expenses	3,572	3,899	4,149	4,342	4,573	4,587	5,115	5,634	5,999	6,627
Selling, General & Admin Expense	3,094	3,391	3,598	3,783	3,975	3,961	4,463	4,920	5,290	5,896
Depreciation Expense	399	417	448	453	490	510	533	582	568	585
Other Operating Expenses / (Income)	79	92	103	106	108	116	119	132	141	146
Total Other Income / (Expense), net	-113	-125	-145	-141	-150	-106	-70	-137	-235	-184
Interest Expense	113	125	145	155	163	106	84	127	207	186
Other Income / (Expense), net	-	0.00	0.00	14	13	0.01	14	-10	-28	2.23
Income Tax Expense	395	409	364	237	239	299	306	209	221	335
Net Income / (Loss) Attributable to Noncontrolling Interest	70	45	19	18	13	8.84	-3.96	-19	1.51	21
Basic Earnings per Share	$6.89	$7.22	$7.86	$8.35	$9.16	$11.06	$11.99	$9.23	$10.35	$17.16
Weighted Average Basic Shares Outstanding	98.80M	97.21M	95.65M	93.28M	88.76M	85.06M	82.52M	73.12M	69.32M	66.55M
Diluted Earnings per Share	$6.76	$7.14	$7.81	$8.31	$9.13	$10.99	$11.82	$9.14	$10.23	$16.82
Weighted Average Diluted Shares Outstanding	100.69M	98.38M	96.33M	93.75M	89.04M	85.59M	83.69M	73.83M	70.13M	67.90M
Weighted Average Basic & Diluted Shares Outstanding	98.80M	97.30M	95.70M	93.40M	86.73M	85.09M	74.81M	70.67M	67.22M	65.00M
Cash Dividends to Common per Share	-	-	-	$0.40	$0.60	-	$0.80	$0.80	$0.80	$0.80

This table shows Universal Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	183	175	163	171	167	216	262	289	259	332
Consolidated Net Income / (Loss)	177	170	162	169	168	220	266	294	266	337
Net Income / (Loss) Continuing Operations	177	170	162	169	168	220	266	294	266	337
Total Pre-Tax Income	234	222	214	225	221	281	336	382	342	438
Total Operating Income	276	261	279	280	285	331	389	436	384	472
Total Gross Profit	1,659	1,746	1,714	1,778	1,778	1,905	2,001	2,051	2,051	2,206
Total Revenue	3,336	3,447	3,468	3,548	3,563	3,704	3,844	3,908	3,963	4,114
Operating Revenue	3,336	3,447	3,468	3,548	3,563	3,704	3,844	3,908	3,963	4,114
Total Cost of Revenue	1,677	1,701	1,753	1,770	1,785	1,799	1,843	1,856	1,912	1,907
Operating Cost of Revenue	1,677	1,701	1,753	1,770	1,785	1,799	1,843	1,856	1,912	1,907
Total Operating Expenses	1,383	1,485	1,435	1,498	1,493	1,573	1,612	1,615	1,667	1,734
Selling, General & Admin Expense	1,204	1,302	1,259	1,319	1,320	1,393	1,436	1,431	1,480	1,549
Depreciation Expense	146	148	142	144	137	145	141	147	150	147
Other Operating Expenses / (Income)	33	35	35	35	35	35	35	36	37	38
Total Other Income / (Expense), net	-42	-39	-65	-55	-65	-50	-53	-54	-43	-34
Interest Expense	36	44	51	49	53	54	53	49	45	40
Other Income / (Expense), net	-6.02	4.84	-14	-6.60	-11	3.52	0.15	-5.49	2.03	5.55
Income Tax Expense	57	52	52	55	52	62	70	88	76	101
Net Income / (Loss) Attributable to Noncontrolling Interest	-6.00	-4.45	-0.74	-2.01	1.02	3.24	3.99	5.18	7.20	4.65
Basic Earnings per Share	$2.52	$2.44	$2.31	$2.44	$2.42	$3.18	$3.90	$4.32	$3.89	$5.05
Weighted Average Basic Shares Outstanding	72.60M	73.12M	70.54M	70.07M	68.87M	69.32M	67.20M	66.88M	66.54M	66.55M
Diluted Earnings per Share	$2.50	$2.42	$2.28	$2.42	$2.40	$3.13	$3.82	$4.26	$3.80	$4.94
Weighted Average Diluted Shares Outstanding	73.06M	73.83M	71.49M	70.84M	69.62M	70.13M	68.48M	67.92M	68.11M	67.90M
Weighted Average Basic & Diluted Shares Outstanding	71.41M	70.67M	70.18M	69.39M	68.26M	67.22M	66.93M	66.71M	65.97M	65.00M

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	29	4.67	45	32	-94	1,173	-1,100	22	14	10
Net Cash From Operating Activities	1,068	1,334	1,248	1,275	1,438	2,360	884	996	1,268	2,067
Net Cash From Continuing Operating Activities	1,068	1,334	1,248	1,275	1,438	2,360	884	996	1,268	2,067
Net Income / (Loss) Continuing Operations	751	747	771	798	828	953	988	657	719	1,163
Consolidated Net Income / (Loss)	751	747	771	798	828	953	988	657	719	1,163
Depreciation Expense	399	417	448	453	490	510	533	582	568	585
Non-Cash Adjustments To Reconcile Net Income	84	93	57	116	160	69	100	144	81	93
Changes in Operating Assets and Liabilities, net	-165	77	-28	-92	-39	828	-737	-386	-101	227
Net Cash From Investing Activities	-913	-1,155	-685	-747	-688	-803	-914	-647	-763	-911
Net Cash From Continuing Investing Activities	-913	-1,155	-685	-747	-688	-803	-914	-647	-763	-911
Purchase of Property, Plant & Equipment	-379	-541	-558	-665	-634	-731	-856	-734	-743	-944
Acquisitions	-534	-614	-23	-110	-8.01	-52	-105	-20	-3.73	-19
Purchase of Investments	-	-	-72	-15	-34	-24	1.36	95	-41	13
Divestitures	3.39	0.00	0.11	14	9.45	8.17	25	12	24	39
Other Investing Activities, net	-3.30	0.00	-32	-36	-21	-3.00	20	0.10	0.02	0.28
Net Cash From Financing Activities	-125	-171	-519	-492	-845	-385	-1,069	-318	-494	-1,145
Net Cash From Continuing Financing Activities	-125	-171	-519	-492	-845	-385	-1,069	-318	-494	-1,145
Repayment of Debt	-69	-472	-143	-844	-57	-973	-3,057	-93	-86	-2,653
Repurchase of Common Equity	-210	-353	-364	-397	-771	-207	-1,221	-833	-547	-671
Payment of Dividends	-102	-108	-63	-52	-69	-19	-60	-112	-60	-47
Issuance of Debt	234	1,171	41	791	39	802	3,255	705	185	2,210
Issuance of Common Equity	8.44	9.50	10	10	12	12	13	14	14	15
Effect of Exchange Rate Changes	-1.61	-	-	-2.91	-	0.74	-0.50	-8.42	3.06	-0.83
Cash Interest Paid	107	107	136	150	157	113	76	120	200	168
Cash Income Taxes Paid	381	345	371	294	261	286	363	251	258	325

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-37	35	8.20	-30	1.33	34	-7.67	17	-19	20
Net Cash From Operating Activities	221	297	291	363	162	452	396	679	333	658
Net Cash From Continuing Operating Activities	221	297	291	363	162	452	396	679	333	658
Net Income / (Loss) Continuing Operations	177	170	162	169	168	220	266	294	266	337
Consolidated Net Income / (Loss)	177	170	162	169	168	220	266	294	266	337
Depreciation Expense	146	148	142	144	137	145	141	147	150	147
Non-Cash Adjustments To Reconcile Net Income	21	80	21	16	23	22	16	27	28	22
Changes in Operating Assets and Liabilities, net	-123	-102	-34	34	-166	65	-26	211	-111	153
Net Cash From Investing Activities	-73	-248	-178	-170	-176	-239	-195	-243	-266	-208
Net Cash From Continuing Investing Activities	-73	-248	-178	-170	-176	-239	-195	-243	-266	-208
Purchase of Property, Plant & Equipment	-162	-164	-169	-168	-200	-206	-209	-241	-248	-246
Acquisitions	-6.18	-1.64	0.00	-3.73	-	-	0.00	-	-	-19
Purchase of Investments	93	-82	-19	-12	24	-33	8.32	-1.49	-42	49
Divestitures	1.77	-	9.26	14	-	0.50	5.43	-	25	8.34
Other Investing Activities, net	-	-	0.00	-	-	0.02	0.16	0.04	0.00	0.08
Net Cash From Financing Activities	-179	-15	-106	-224	18	-182	-209	-420	-90	-427
Net Cash From Continuing Financing Activities	-179	-15	-106	-224	18	-182	-209	-420	-90	-427
Repayment of Debt	33	104	-17	-77	40	-31	-64	-319	-2,099	-171
Repurchase of Common Equity	-158	-110	-85	-125	-176	-162	-142	-96	-183	-250
Payment of Dividends	-62	-14	-18	-14	-14	-13	-18	-8.83	-10	-9.74
Issuance of Common Equity	3.74	3.67	2.99	3.61	3.24	3.81	3.24	3.99	3.64	4.21
Effect of Exchange Rate Changes	-	-	-	-	-1.88	2.56	-	-	3.09	-3.53
Cash Interest Paid	35	41	50	47	52	51	48	48	48	24
Cash Income Taxes Paid	37	69	2.36	131	57	67	2.67	129	105	88

This table presents Universal Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	9,615	10,318	10,762	11,265	11,668	13,477	13,094	13,494	13,968	14,470
Total Current Assets	1,718	1,681	1,798	1,938	1,916	3,282	2,264	2,537	2,811	2,816
Cash & Equivalents	61	34	74	105	61	1,224	115	103	119	126
Accounts Receivable	1,302	1,440	1,501	1,510	1,561	1,729	1,747	2,018	2,238	2,178
Inventories, net	116	125	136	148	160	190	207	219	217	221
Other Current Assets	103	83	87	174	134	138	195	198	237	292
Plant, Property, & Equipment, net	3,836	4,331	4,572	4,848	5,017	5,373	5,874	5,918	6,125	6,572
Plant, Property & Equipment, gross	6,531	7,314	7,921	8,519	9,106	9,886	10,771	11,086	11,777	12,643
Accumulated Depreciation	2,695	2,983	3,349	3,716	4,090	4,513	4,896	5,167	5,653	6,071
Total Noncurrent Assets	11,766	4,305	4,392	4,474	4,736	4,822	4,956	5,038	5,032	5,081
Goodwill	3,596	3,784	3,825	3,845	3,870	3,883	3,963	3,909	3,932	3,933
Noncurrent Deferred & Refundable Income Taxes	0.00	1.23	3.01	-	16	23	46	68	86	118
Other Noncurrent Operating Assets	8,170	520	564	630	850	916	947	1,061	580	1,030
Total Liabilities & Shareholders' Equity	9,615	10,318	10,762	11,265	11,668	13,477	13,094	13,494	13,968	14,470
Total Liabilities	5,064	5,711	5,704	5,795	6,085	7,070	6,895	7,524	7,766	7,707
Total Current Liabilities	1,100	1,317	1,848	1,449	1,563	2,481	1,984	1,914	2,013	2,210
Short-Term Debt	63	106	546	63	88	332	48	81	127	40
Accounts Payable	366	440	442	446	447	571	659	637	614	632
Accrued Expenses	349	403	389	389	354	526	560	524	473	635
Current Deferred Revenue	-	-	-	-	0.00	376	0.01	2.40	5.38	0.00
Current Deferred & Payable Income Tax Liabilities	3.99	2.15	18	2.43	2.52	44	11	4.61	2.05	14
Current Employee Benefit Liabilities	245	275	305	343	380	410	466	471	549	623
Other Taxes Payable	60	68	86	56	72	152	161	111	154	162
Other Current Liabilities	-	-	39	129	201	60	64	68	72	75
Other Current Nonoperating Liabilities	13	23	24	19	19	9.46	14	16	17	30
Total Noncurrent Liabilities	3,963	4,394	3,856	4,347	4,522	4,589	4,911	5,610	5,752	5,497
Long-Term Debt	3,369	4,030	3,494	3,935	3,897	3,524	4,142	4,727	4,786	4,464
Capital Lease Obligations	-	-	-	-	270	601	-	396	-	376
Other Noncurrent Operating Liabilities	279	275	306	362	330	459	769	488	967	656
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	243	9.32	6.70	4.29	4.33	4.57	5.12	4.70	5.19	13
Total Equity & Noncontrolling Interests	4,309	4,598	5,051	5,466	5,579	6,402	6,193	5,965	6,197	6,750
Total Preferred & Common Equity	4,250	4,533	4,990	5,389	5,503	6,317	6,090	5,921	6,149	6,666
Total Common Equity	4,250	4,533	4,990	5,389	5,503	6,317	6,090	5,921	6,149	6,666
Common Stock	0.98	0.97	0.94	0.91	0.00	0.85	0.77	0.71	0.67	0.65
Retained Earnings	4,272	4,558	4,981	5,384	5,471	6,268	6,604	5,930	6,139	6,658
Accumulated Other Comprehensive Income / (Loss)	-23	-25	7.18	4.24	32	48	30	-9.67	9.29	7.20
Noncontrolling Interest	60	64	62	77	75	85	103	45	48	83

This table presents Universal Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Total Assets	13,379	13,494	13,556	13,732	13,873	13,968	14,046	14,071	14,354	14,470
Total Current Assets	2,457	2,537	2,559	2,625	2,753	2,811	2,871	2,741	2,802	2,816
Cash & Equivalents	75	103	110	79	81	119	112	129	106	126
Accounts Receivable	1,902	2,018	2,032	2,103	2,234	2,238	2,299	2,157	2,214	2,178
Inventories, net	218	219	216	215	215	217	216	219	220	221
Other Current Assets	262	198	201	226	223	237	243	236	262	292
Plant, Property, & Equipment, net	5,936	5,918	5,954	6,028	6,087	6,125	6,185	6,335	6,443	6,572
Plant, Property & Equipment, gross	11,104	11,086	11,251	11,442	11,610	11,777	11,955	12,240	12,448	12,643
Accumulated Depreciation	5,167	5,167	5,297	5,414	5,523	5,653	5,770	5,905	6,006	6,071
Total Noncurrent Assets	4,986	5,038	5,043	5,080	5,033	5,032	4,990	4,996	5,109	5,081
Goodwill	3,874	3,909	3,914	3,930	3,912	3,932	3,928	3,942	3,965	3,933
Noncurrent Deferred & Refundable Income Taxes	56	68	91	110	100	86	95	108	122	118
Other Noncurrent Operating Assets	1,056	1,061	1,038	1,040	1,022	580	967	946	1,022	1,030
Total Liabilities & Shareholders' Equity	13,379	13,494	13,556	13,732	13,873	13,968	14,046	14,071	14,354	14,470
Total Liabilities	7,470	7,524	7,499	7,599	7,762	7,766	7,735	7,515	7,667	7,707
Total Current Liabilities	1,939	1,914	1,863	2,035	1,990	2,013	2,075	2,149	2,011	2,210
Short-Term Debt	66	81	96	111	127	127	127	128	38	40
Accounts Payable	1,795	637	1,636	1,843	1,783	614	1,830	1,926	1,896	632
Accrued Expenses	-	524	-	-	-	473	-	-	-	635
Current Deferred Revenue	-	2.40	-	-	-	5.38	-	-	-	0.00
Current Deferred & Payable Income Tax Liabilities	7.74	4.61	58	6.96	7.15	2.05	47	23	3.80	14
Current Employee Benefit Liabilities	-	471	-	-	-	549	-	-	-	623
Other Taxes Payable	-	111	-	-	-	154	-	-	-	162
Other Current Liabilities	70	68	73	74	73	72	71	72	73	75
Other Current Nonoperating Liabilities	-	16	-	-	-	17	-	-	-	30
Total Noncurrent Liabilities	5,531	5,610	5,636	5,564	5,772	5,752	5,660	5,366	5,656	5,497
Long-Term Debt	4,638	4,727	4,707	4,605	4,796	4,786	4,734	4,417	4,618	4,464
Capital Lease Obligations	393	396	396	388	389	-	374	380	378	376
Other Noncurrent Operating Liabilities	500	488	532	571	588	967	551	570	660	656
Commitments & Contingencies	-	0.00	-	-	-	0.00	-	-	-	0.00
Redeemable Noncontrolling Interest	4.56	4.70	4.27	4.21	4.72	5.19	4.99	5.42	5.62	13
Total Equity & Noncontrolling Interests	5,904	5,965	6,052	6,129	6,106	6,197	6,306	6,551	6,681	6,750
Total Preferred & Common Equity	5,855	5,921	0.00	6,087	6,065	6,149	6,257	6,485	6,606	6,666
Total Common Equity	5,855	5,921	0.00	6,087	6,065	6,149	6,257	6,485	6,606	6,666
Common Stock	5,855	0.71	-	6,087	6,065	0.67	6,257	6,485	6,606	0.65
Retained Earnings	-	5,930	-	-	-	6,139	-	-	-	6,658
Accumulated Other Comprehensive Income / (Loss)	-	-9.67	-	-	-	9.29	-	-	-	7.20
Noncontrolling Interest	49	45	6,052	42	42	48	49	65	75	83

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.22%	7.99%	6.59%	3.48%	5.63%	1.59%	9.37%	5.99%	6.59%	10.82%
EBITDA Growth	15.23%	2.41%	1.77%	-4.95%	4.68%	8.69%	2.21%	-17.55%	8.90%	32.29%
EBIT Growth	18.44%	1.75%	-0.10%	-7.08%	3.33%	10.52%	1.37%	-27.88%	15.50%	46.81%
NOPAT Growth	19.23%	0.35%	5.07%	4.19%	4.10%	9.54%	0.70%	-26.88%	18.12%	45.26%
Net Income Growth	24.08%	-0.47%	3.23%	3.44%	3.72%	15.13%	3.66%	-33.48%	9.49%	61.70%
EPS Growth	24.72%	5.62%	9.38%	6.40%	9.87%	20.37%	7.55%	-22.67%	11.93%	64.42%
Operating Cash Flow Growth	3.13%	24.86%	-6.47%	2.18%	12.84%	64.08%	-62.56%	12.71%	27.29%	63.05%
Free Cash Flow Firm Growth	1.34%	2,652.50%	-92.83%	3.89%	-8.83%	124.67%	-65.95%	-109.53%	2,642.29%	-20.87%
Invested Capital Growth	7.77%	-44.17%	3.61%	3.65%	4.46%	-1.50%	6.62%	7.77%	-0.67%	4.86%
Revenue Q/Q Growth	-0.17%	3.34%	1.63%	1.05%	1.26%	1.68%	1.51%	1.30%	1.83%	2.66%
EBITDA Q/Q Growth	0.26%	-0.18%	1.82%	-3.55%	7.68%	3.79%	-4.83%	-2.76%	3.98%	6.81%
EBIT Q/Q Growth	-0.04%	-0.59%	1.95%	-5.16%	10.12%	4.78%	-6.54%	-5.67%	6.35%	9.30%
NOPAT Q/Q Growth	-0.11%	-1.23%	6.49%	-5.04%	6.60%	5.43%	-6.92%	-4.89%	6.99%	8.69%
Net Income Q/Q Growth	0.11%	-1.66%	6.39%	-7.15%	11.36%	6.69%	-6.95%	-8.82%	7.35%	11.23%
EPS Q/Q Growth	0.60%	0.42%	7.28%	-6.63%	13.42%	7.64%	-4.68%	-5.97%	7.46%	12.06%
Operating Cash Flow Q/Q Growth	-6.52%	-5.29%	15.94%	-3.30%	0.56%	-7.50%	25.58%	-2.42%	13.94%	11.07%
Free Cash Flow Firm Q/Q Growth	-148.06%	2,542.46%	1,204.47%	20.49%	-18.10%	-34.07%	15,366.04%	80.25%	126.45%	-17.02%
Invested Capital Q/Q Growth	108.56%	8.55%	1.52%	-0.11%	1.70%	9.38%	3.53%	1.42%	-2.90%	-0.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.42%	53.05%	52.15%	51.22%	50.88%	51.44%	51.24%	49.53%	50.23%	52.50%
EBITDA Margin	18.33%	17.39%	16.60%	15.25%	15.11%	16.17%	15.11%	11.75%	12.01%	14.33%
Operating Margin	13.93%	13.12%	12.30%	10.91%	10.69%	11.75%	10.78%	7.49%	8.23%	10.63%
EBIT Margin	13.93%	13.12%	12.30%	11.04%	10.80%	11.75%	10.89%	7.41%	8.03%	10.64%
Profit (Net Income) Margin	8.30%	7.65%	7.41%	7.41%	7.27%	8.24%	7.81%	4.90%	5.04%	7.35%
Tax Burden Percent	65.51%	64.61%	67.96%	77.13%	77.61%	76.10%	76.36%	75.84%	76.49%	77.65%
Interest Burden Percent	90.99%	90.24%	88.66%	86.97%	86.76%	92.18%	93.92%	87.22%	81.98%	88.95%
Effective Tax Rate	34.49%	35.39%	32.04%	22.87%	22.39%	23.90%	23.64%	24.16%	23.51%	22.35%
Return on Invested Capital (ROIC)	5.47%	6.79%	9.79%	9.84%	9.84%	10.63%	10.44%	7.12%	8.14%	11.58%
ROIC Less NNEP Spread (ROIC-NNEP)	4.78%	5.73%	7.35%	7.09%	6.98%	8.46%	8.99%	4.86%	4.52%	8.60%
Return on Net Nonoperating Assets (RNNOA)	12.02%	9.52%	6.17%	5.32%	5.13%	5.26%	5.23%	3.68%	3.68%	6.37%
Return on Equity (ROE)	17.49%	16.32%	15.96%	15.16%	14.97%	15.89%	15.67%	10.80%	11.82%	17.94%
Cash Return on Invested Capital (CROIC)	-2.01%	63.48%	6.24%	6.26%	5.48%	12.14%	4.03%	-0.36%	8.81%	6.83%
Operating Return on Assets (OROA)	13.55%	12.86%	12.15%	10.80%	10.72%	10.80%	10.36%	7.47%	8.35%	11.84%
Return on Assets (ROA)	8.08%	7.50%	7.32%	7.24%	7.22%	7.58%	7.43%	4.94%	5.24%	8.18%
Return on Common Equity (ROCE)	16.28%	15.65%	15.73%	14.94%	14.76%	15.67%	15.42%	10.66%	11.72%	17.74%
Return on Equity Simple (ROE_SIMPLE)	17.66%	16.48%	15.46%	14.81%	15.04%	15.08%	16.22%	11.10%	11.70%	17.45%
Net Operating Profit after Tax (NOPAT)	825	828	870	906	944	1,034	1,041	761	899	1,306
NOPAT Margin	9.12%	8.48%	8.36%	8.41%	8.29%	8.94%	8.23%	5.68%	6.29%	8.25%
Net Nonoperating Expense Percent (NNEP)	0.69%	1.06%	2.43%	2.75%	2.86%	2.17%	1.45%	2.26%	3.62%	2.98%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	6.81%	8.09%	11.23%
Cost of Revenue to Revenue	46.58%	46.95%	47.85%	48.78%	49.12%	48.56%	48.76%	50.47%	49.77%	47.50%
SG&A Expenses to Revenue	34.21%	34.72%	34.56%	35.12%	34.94%	34.27%	35.30%	36.72%	37.04%	37.25%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	39.49%	39.93%	39.86%	40.31%	40.19%	39.69%	40.46%	42.04%	42.00%	41.87%
Earnings before Interest and Taxes (EBIT)	1,259	1,281	1,280	1,189	1,229	1,358	1,377	993	1,147	1,684
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,658	1,698	1,728	1,643	1,719	1,869	1,910	1,575	1,715	2,269
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.67	2.20	2.09	1.95	2.23	1.81	1.69	1.68	1.69	1.78
Price to Tangible Book Value (P/TBV)	17.36	13.32	8.97	6.80	7.53	4.70	4.83	4.95	4.68	4.33
Price to Revenue (P/Rev)	1.25	1.02	1.00	0.98	1.08	0.99	0.81	0.74	0.73	0.75
Price to Earnings (P/E)	16.67	14.21	13.88	13.47	15.09	12.13	10.36	14.74	14.44	10.36
Dividend Yield	0.35%	0.39%	0.36%	0.35%	0.43%	0.52%	0.63%	0.57%	0.53%	0.45%
Earnings Yield	6.00%	7.04%	7.20%	7.42%	6.63%	8.24%	9.66%	6.78%	6.93%	9.65%
Enterprise Value to Invested Capital (EV/IC)	0.96	1.62	1.60	1.54	1.69	1.53	1.40	1.36	1.38	1.45
Enterprise Value to Revenue (EV/Rev)	1.66	1.45	1.39	1.34	1.46	1.28	1.14	1.13	1.06	1.05
Enterprise Value to EBITDA (EV/EBITDA)	9.06	8.34	8.38	8.81	9.63	7.90	7.57	9.59	8.87	7.35
Enterprise Value to EBIT (EV/EBIT)	11.93	11.05	11.31	12.17	13.48	10.87	10.50	15.22	13.26	9.91
Enterprise Value to NOPAT (EV/NOPAT)	18.20	17.10	16.64	15.97	17.55	14.29	13.89	19.85	16.92	12.78
Enterprise Value to Operating Cash Flow (EV/OCF)	14.06	10.61	11.61	11.36	11.52	6.26	16.36	15.17	12.00	8.07
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	1.83	26.10	25.12	31.52	12.51	35.95	0.00	15.62	21.66
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.75	0.90	0.80	0.73	0.76	0.70	0.68	0.87	0.79	0.72
Long-Term Debt to Equity	0.74	0.87	0.69	0.72	0.75	0.64	0.67	0.86	0.77	0.72
Financial Leverage	2.51	1.66	0.84	0.75	0.73	0.62	0.58	0.76	0.82	0.74
Leverage Ratio	2.17	2.18	2.18	2.09	2.07	2.10	2.11	2.19	2.26	2.19
Compound Leverage Factor	1.97	1.96	1.93	1.82	1.80	1.93	1.98	1.91	1.85	1.95
Debt to Total Capital	42.98%	47.31%	44.40%	42.23%	43.25%	41.03%	40.34%	46.57%	44.20%	41.92%
Short-Term Debt to Total Capital	0.79%	1.21%	6.00%	0.67%	0.89%	3.06%	0.47%	0.73%	1.14%	0.34%
Long-Term Debt to Total Capital	42.20%	46.10%	38.41%	41.56%	42.36%	37.97%	39.87%	45.84%	43.06%	41.57%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.78%	0.84%	0.75%	0.85%	0.80%	0.82%	1.04%	0.44%	0.48%	0.83%
Common Equity to Total Capital	53.23%	51.85%	54.84%	56.92%	55.94%	58.15%	58.62%	52.99%	55.32%	57.25%
Debt to EBITDA	2.07	2.44	2.34	2.43	2.47	2.39	2.19	3.30	2.86	2.15
Net Debt to EBITDA	2.03	2.42	2.29	2.37	2.44	1.73	2.13	3.24	2.79	2.10
Long-Term Debt to EBITDA	2.03	2.37	2.02	2.40	2.42	2.21	2.17	3.25	2.79	2.13
Debt to NOPAT	4.16	5.00	4.64	4.41	4.51	4.31	4.03	6.84	5.46	3.74
Net Debt to NOPAT	4.08	4.95	4.56	4.30	4.44	3.13	3.91	6.70	5.33	3.64
Long-Term Debt to NOPAT	4.08	4.87	4.02	4.34	4.42	3.99	3.98	6.73	5.32	3.71
Altman Z-Score	3.42	3.07	3.10	3.11	3.23	2.88	2.94	2.70	2.78	3.09
Noncontrolling Interest Sharing Ratio	6.95%	4.10%	1.47%	1.42%	1.45%	1.41%	1.57%	1.30%	0.84%	1.15%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.56	1.28	0.97	1.34	1.23	1.32	1.14	1.33	1.40	1.27
Quick Ratio	1.24	1.12	0.85	1.11	1.04	1.19	0.94	1.11	1.17	1.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-303	7,736	555	576	525	1,181	402	-38	974	770
Operating Cash Flow to CapEx	281.62%	246.36%	223.78%	191.70%	226.85%	322.73%	103.28%	135.70%	170.62%	219.02%
Free Cash Flow to Firm to Interest Expense	-2.67	61.86	3.82	3.72	3.23	11.11	4.80	-0.30	4.71	4.14
Operating Cash Flow to Interest Expense	9.41	10.67	8.59	8.23	8.84	22.21	10.56	7.85	6.13	11.11
Operating Cash Flow Less CapEx to Interest Expense	6.07	6.34	4.75	3.94	4.94	15.33	0.34	2.07	2.54	6.04
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.97	0.98	0.99	0.98	0.99	0.92	0.95	1.01	1.04	1.11
Accounts Receivable Turnover	7.00	7.12	7.08	7.16	7.41	7.03	7.27	7.12	6.71	7.17
Inventory Turnover	37.59	37.99	38.09	36.95	36.28	32.05	31.03	31.80	32.64	34.34
Fixed Asset Turnover	2.41	2.39	2.34	2.29	2.31	2.23	2.25	2.27	2.37	2.49
Accounts Payable Turnover	11.99	11.38	11.30	11.84	12.52	11.03	10.03	10.44	11.37	12.07
Days Sales Outstanding (DSO)	52.17	51.24	51.55	51.01	49.25	51.94	50.17	51.27	54.38	50.92
Days Inventory Outstanding (DIO)	9.71	9.61	9.58	9.88	10.06	11.39	11.76	11.48	11.18	10.63
Days Payable Outstanding (DPO)	30.44	32.07	32.31	30.83	29.15	33.08	36.40	34.96	32.11	30.24
Cash Conversion Cycle (CCC)	31.44	28.77	28.83	30.06	30.17	30.25	25.53	27.79	33.46	31.30
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	15,640	8,732	9,047	9,377	9,796	9,649	10,288	11,087	11,012	11,548
Invested Capital Turnover	0.60	0.80	1.17	1.17	1.19	1.19	1.27	1.25	1.29	1.40
Increase / (Decrease) in Invested Capital	1,128	-6,908	315	330	418	-147	639	799	-75	535
Enterprise Value (EV)	15,019	14,154	14,480	14,477	16,564	14,772	14,453	15,111	15,208	16,687
Market Capitalization	11,347	9,978	10,445	10,503	12,292	11,449	10,270	9,961	10,362	11,836
Book Value per Share	$43.16	$46.76	$52.57	$58.25	$62.84	$74.34	$75.76	$82.91	$90.08	$101.06
Tangible Book Value per Share	$6.64	$7.73	$12.27	$16.70	$18.65	$28.65	$26.46	$28.16	$32.47	$41.44
Total Capital	7,983	8,743	9,098	9,469	9,837	10,864	10,388	11,174	11,114	11,644
Total Debt	3,431	4,136	4,040	3,999	4,254	4,457	4,190	5,204	4,912	4,881
Total Long-Term Debt	3,369	4,030	3,494	3,935	4,167	4,125	4,142	5,122	4,786	4,841
Net Debt	3,370	4,102	3,966	3,893	4,193	3,233	4,075	5,101	4,793	4,755
Capital Expenditures (CapEx)	379	541	558	665	634	731	856	734	743	944
Debt-free, Cash-free Net Working Capital (DFCFNWC)	619	436	421	447	379	-92	213	602	805	520
Debt-free Net Working Capital (DFNWC)	681	470	496	553	440	1,133	328	704	925	646
Net Working Capital (NWC)	618	364	-50	489	353	801	279	623	798	606
Net Nonoperating Expense (NNE)	74	81	99	109	116	81	53	104	180	143
Net Nonoperating Obligations (NNO)	11,088	4,125	3,989	3,907	4,212	3,242	4,089	5,117	4,810	4,785
Total Depreciation and Amortization (D&A)	399	417	448	453	490	510	533	582	568	585
Debt-free, Cash-free Net Working Capital to Revenue	6.85%	4.47%	4.05%	4.15%	3.33%	-0.79%	1.68%	4.49%	5.64%	3.29%
Debt-free Net Working Capital to Revenue	7.53%	4.81%	4.76%	5.13%	3.87%	9.80%	2.59%	5.26%	6.47%	4.08%
Net Working Capital to Revenue	6.83%	3.73%	-0.48%	4.54%	3.10%	6.93%	2.21%	4.65%	5.59%	3.83%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$6.89	$7.22	$7.86	$8.35	$9.16	$11.06	$11.99	$9.23	$10.35	$17.16
Adjusted Weighted Average Basic Shares Outstanding	98.80M	97.21M	95.65M	93.28M	88.76M	85.06M	82.52M	73.12M	69.32M	66.55M
Adjusted Diluted Earnings per Share	$6.76	$7.14	$7.81	$8.31	$9.13	$10.99	$11.82	$9.14	$10.23	$16.82
Adjusted Weighted Average Diluted Shares Outstanding	100.69M	98.38M	96.33M	93.75M	89.04M	85.59M	83.69M	73.83M	70.13M	67.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	97.67M	96.60M	94.27M	90.78M	86.73M	85.09M	74.81M	70.67M	67.22M	65.00M
Normalized Net Operating Profit after Tax (NOPAT)	825	828	870	906	944	1,034	1,041	761	899	1,306
Normalized NOPAT Margin	9.12%	8.48%	8.36%	8.41%	8.29%	8.94%	8.23%	5.68%	6.29%	8.25%
Pre Tax Income Margin	12.67%	11.84%	10.90%	9.60%	9.37%	10.83%	10.23%	6.46%	6.58%	9.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.10	10.25	8.82	7.68	7.55	12.78	16.46	7.83	5.55	9.05
NOPAT to Interest Expense	7.27	6.62	5.99	5.85	5.80	9.73	12.44	6.00	4.35	7.02
EBIT Less CapEx to Interest Expense	7.75	5.92	4.98	3.39	3.66	5.90	6.23	2.04	1.96	3.98
NOPAT Less CapEx to Interest Expense	3.93	2.29	2.15	1.56	1.90	2.84	2.21	0.21	0.75	1.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	13.55%	14.52%	8.16%	6.51%	8.32%	2.01%	6.05%	17.10%	8.28%	4.03%
Augmented Payout Ratio	41.50%	61.81%	55.40%	56.32%	101.43%	23.71%	129.67%	143.88%	84.37%	61.70%

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.70%	5.24%	5.30%	6.76%	6.80%	7.44%	10.85%	10.13%	11.23%	11.08%
EBITDA Growth	-6.06%	-9.74%	11.26%	10.02%	-1.12%	15.83%	30.33%	38.61%	30.33%	30.12%
EBIT Growth	-12.41%	-18.33%	19.54%	16.19%	1.49%	25.73%	46.77%	57.54%	41.01%	42.82%
NOPAT Growth	-13.48%	-16.26%	20.20%	19.43%	4.39%	29.18%	45.47%	59.30%	37.57%	40.42%
Net Income Growth	-19.40%	-27.17%	7.52%	6.63%	-4.98%	28.91%	63.71%	73.85%	58.27%	53.47%
EPS Growth	-3.85%	-19.33%	12.87%	10.00%	-4.00%	29.34%	67.54%	76.03%	58.33%	57.83%
Operating Cash Flow Growth	-50.10%	-7.68%	-34.73%	1,012.86%	-26.74%	52.18%	36.34%	87.16%	105.97%	45.53%
Free Cash Flow Firm Growth	10.19%	-49.88%	43.75%	65.40%	75.46%	155.64%	104.11%	169.49%	113.49%	-151.65%
Invested Capital Growth	10.00%	7.77%	6.51%	3.88%	3.75%	-0.67%	2.59%	1.74%	2.41%	4.86%
Revenue Q/Q Growth	0.38%	3.33%	0.60%	2.33%	0.41%	3.95%	3.78%	1.67%	1.42%	3.80%
EBITDA Q/Q Growth	9.62%	-0.28%	-1.92%	2.62%	-1.48%	16.81%	10.35%	9.15%	-7.37%	16.62%
EBIT Q/Q Growth	14.64%	-1.35%	-0.47%	3.23%	0.13%	22.21%	16.19%	10.80%	-10.38%	23.78%
NOPAT Q/Q Growth	17.85%	-3.83%	5.53%	-0.14%	3.01%	19.01%	18.84%	9.35%	-11.04%	21.47%
Net Income Q/Q Growth	11.36%	-3.64%	-4.69%	4.27%	-0.76%	30.72%	21.04%	10.72%	-9.66%	26.75%
EPS Q/Q Growth	13.64%	-3.20%	-5.79%	6.14%	-0.83%	30.42%	22.04%	11.52%	-10.80%	30.00%
Operating Cash Flow Q/Q Growth	576.62%	34.73%	-2.20%	24.83%	-55.46%	179.86%	-12.38%	71.36%	-50.98%	97.74%
Free Cash Flow Firm Q/Q Growth	-32.46%	23.76%	21.60%	56.29%	6.04%	272.82%	160.80%	638.20%	-81.75%	-761.44%
Invested Capital Q/Q Growth	1.77%	1.42%	0.54%	0.10%	1.65%	-2.90%	0.50%	-0.73%	2.32%	-0.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.72%	50.65%	49.44%	50.11%	49.90%	51.42%	52.06%	52.49%	51.75%	53.63%
EBITDA Margin	12.46%	12.03%	11.73%	11.76%	11.54%	12.97%	13.79%	14.80%	13.52%	15.19%
Operating Margin	8.27%	7.58%	8.04%	7.90%	8.01%	8.94%	10.11%	11.17%	9.69%	11.49%
EBIT Margin	8.09%	7.72%	7.64%	7.71%	7.69%	9.04%	10.12%	11.03%	9.74%	11.62%
Profit (Net Income) Margin	5.30%	4.94%	4.68%	4.77%	4.72%	5.93%	6.92%	7.53%	6.71%	8.19%
Tax Burden Percent	75.49%	76.63%	75.84%	75.35%	76.19%	78.12%	79.09%	77.05%	77.86%	76.90%
Interest Burden Percent	86.79%	83.51%	80.80%	82.15%	80.51%	83.99%	86.42%	88.65%	88.44%	91.69%
Effective Tax Rate	24.51%	23.37%	24.16%	24.65%	23.81%	21.88%	20.91%	22.95%	22.14%	23.10%
Return on Invested Capital (ROIC)	7.91%	7.29%	7.66%	7.50%	7.69%	9.03%	10.39%	11.48%	10.14%	12.39%
ROIC Less NNEP Spread (ROIC-NNEP)	7.18%	6.64%	6.64%	6.65%	6.72%	8.24%	9.57%	10.63%	9.48%	11.85%
Return on Net Nonoperating Assets (RNNOA)	5.02%	5.02%	5.29%	5.44%	5.73%	6.72%	7.90%	8.22%	7.53%	8.77%
Return on Equity (ROE)	12.94%	12.31%	12.95%	12.94%	13.42%	15.75%	18.29%	19.71%	17.67%	21.16%
Cash Return on Invested Capital (CROIC)	-1.86%	-0.36%	1.07%	3.79%	3.86%	8.81%	6.26%	8.23%	8.09%	6.83%
Operating Return on Assets (OROA)	8.16%	7.78%	7.77%	7.87%	7.91%	9.40%	10.75%	11.91%	10.65%	12.94%
Return on Assets (ROA)	5.35%	4.98%	4.76%	4.87%	4.85%	6.17%	7.35%	8.14%	7.33%	9.12%
Return on Common Equity (ROCE)	6.17%	12.15%	6.32%	12.79%	13.31%	15.62%	9.25%	19.53%	17.49%	20.92%
Return on Equity Simple (ROE_SIMPLE)	12.31%	0.00%	0.00%	11.15%	11.05%	0.00%	13.15%	14.61%	15.83%	0.00%
Net Operating Profit after Tax (NOPAT)	208	200	211	211	217	259	307	336	299	363
NOPAT Margin	6.24%	5.81%	6.10%	5.95%	6.10%	6.99%	8.00%	8.60%	7.55%	8.83%
Net Nonoperating Expense Percent (NNEP)	0.73%	0.65%	1.02%	0.85%	0.96%	0.79%	0.82%	0.85%	0.65%	0.55%
Return On Investment Capital (ROIC_SIMPLE)	-	1.79%	-	-	-	2.33%	-	-	-	3.12%
Cost of Revenue to Revenue	50.28%	49.35%	50.56%	49.89%	50.10%	48.58%	47.94%	47.51%	48.25%	46.37%
SG&A Expenses to Revenue	36.08%	37.76%	36.31%	37.16%	37.05%	37.60%	37.35%	36.63%	37.36%	37.65%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	41.45%	43.07%	41.40%	42.21%	41.89%	42.48%	41.95%	41.33%	42.05%	42.15%
Earnings before Interest and Taxes (EBIT)	270	266	265	274	274	335	389	431	386	478
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	416	415	407	417	411	480	530	578	536	625
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.09	1.68	0.00	1.81	1.43	1.69	1.99	1.91	2.31	1.78
Price to Tangible Book Value (P/TBV)	3.22	4.95	0.00	5.11	4.03	4.68	5.34	4.87	5.79	4.33
Price to Revenue (P/Rev)	0.48	0.74	0.66	0.80	0.62	0.73	0.85	0.82	0.99	0.75
Price to Earnings (P/E)	8.61	14.74	13.03	15.92	12.84	14.44	15.24	13.25	14.89	10.36
Dividend Yield	0.92%	0.57%	0.63%	0.51%	0.64%	0.53%	0.44%	0.43%	0.35%	0.45%
Earnings Yield	11.61%	6.78%	7.68%	6.28%	7.79%	6.93%	6.56%	7.55%	6.72%	9.65%
Enterprise Value to Invested Capital (EV/IC)	1.05	1.36	1.80	1.44	1.23	1.38	1.54	1.52	1.75	1.45
Enterprise Value to Revenue (EV/Rev)	0.87	1.13	1.48	1.17	1.00	1.06	1.20	1.15	1.32	1.05
Enterprise Value to EBITDA (EV/EBITDA)	7.07	9.59	12.42	9.72	8.46	8.87	9.58	8.62	9.55	7.35
Enterprise Value to EBIT (EV/EBIT)	10.87	15.22	19.36	14.97	12.94	13.26	13.86	12.07	13.17	9.91
Enterprise Value to NOPAT (EV/NOPAT)	14.31	19.85	25.19	19.35	16.62	16.92	17.70	15.39	16.88	12.78
Enterprise Value to Operating Cash Flow (EV/OCF)	11.22	15.17	23.85	13.73	12.55	12.00	12.83	10.20	10.90	8.07
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	173.61	38.79	32.47	15.62	24.91	18.61	21.85	21.66
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.86	0.87	0.86	0.83	0.87	0.79	0.83	0.75	0.75	0.72
Long-Term Debt to Equity	0.85	0.86	0.84	0.81	0.85	0.77	0.81	0.73	0.75	0.72
Financial Leverage	0.70	0.76	0.80	0.82	0.85	0.82	0.83	0.77	0.79	0.74
Leverage Ratio	2.14	2.19	2.22	2.24	2.27	2.26	2.23	2.19	2.21	2.19
Compound Leverage Factor	1.85	1.82	1.79	1.84	1.83	1.89	1.93	1.94	1.95	2.01
Debt to Total Capital	46.31%	46.57%	46.20%	45.42%	46.50%	44.20%	45.35%	42.89%	42.95%	41.92%
Short-Term Debt to Total Capital	0.60%	0.73%	0.85%	0.99%	1.11%	1.14%	1.10%	1.11%	0.33%	0.34%
Long-Term Debt to Total Capital	45.71%	45.84%	45.34%	44.43%	45.39%	43.06%	44.24%	41.78%	42.62%	41.57%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.48%	0.44%	53.81%	0.41%	0.41%	0.48%	0.47%	0.62%	0.69%	0.83%
Common Equity to Total Capital	53.20%	52.99%	0.00%	54.17%	53.10%	55.32%	54.18%	56.49%	56.36%	57.25%
Debt to EBITDA	3.15	3.30	3.22	3.09	3.22	2.86	2.85	2.46	2.37	2.15
Net Debt to EBITDA	3.10	3.24	3.15	3.04	3.17	2.79	2.79	2.40	2.32	2.10
Long-Term Debt to EBITDA	3.11	3.25	3.16	3.02	3.14	2.79	2.78	2.40	2.35	2.13
Debt to NOPAT	6.37	6.84	6.53	6.14	6.32	5.46	5.26	4.40	4.19	3.74
Net Debt to NOPAT	6.28	6.70	6.39	6.05	6.22	5.33	5.15	4.28	4.10	3.64
Long-Term Debt to NOPAT	6.29	6.73	6.41	6.01	6.17	5.32	5.13	4.28	4.16	3.71
Altman Z-Score	1.61	2.52	1.84	1.99	1.81	2.59	2.17	2.21	2.42	2.82
Noncontrolling Interest Sharing Ratio	52.32%	1.30%	51.20%	1.16%	0.83%	0.84%	49.41%	0.92%	0.99%	1.15%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.27	1.33	1.37	1.29	1.38	1.40	1.38	1.28	1.39	1.27
Quick Ratio	1.02	1.11	1.15	1.07	1.16	1.17	1.16	1.06	1.15	1.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-786	-599	-470	-205	-193	333	19	143	26	-172
Operating Cash Flow to CapEx	136.56%	180.79%	172.30%	216.15%	80.83%	219.21%	190.09%	281.40%	134.30%	267.72%
Free Cash Flow to Firm to Interest Expense	-22.04	-13.65	-9.23	-4.20	-3.61	6.22	0.37	2.92	0.58	-4.33
Operating Cash Flow to Interest Expense	6.19	6.77	5.71	7.43	3.03	8.44	7.50	13.89	7.46	16.58
Operating Cash Flow Less CapEx to Interest Expense	1.66	3.03	2.40	3.99	-0.72	4.59	3.56	8.95	1.90	10.38
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.01	1.01	1.02	1.02	1.03	1.04	1.06	1.08	1.09	1.11
Accounts Receivable Turnover	7.22	7.12	7.17	7.01	6.78	6.71	6.77	7.05	6.93	7.17
Inventory Turnover	31.78	31.80	32.14	32.48	32.42	32.64	33.30	33.55	34.10	34.34
Fixed Asset Turnover	2.28	2.27	2.29	2.30	2.33	2.37	2.42	2.43	2.46	2.49
Accounts Payable Turnover	3.67	10.44	3.78	3.73	3.92	11.37	4.15	3.86	4.03	12.07
Days Sales Outstanding (DSO)	50.59	51.27	50.92	52.09	53.83	54.38	53.93	51.77	52.66	50.92
Days Inventory Outstanding (DIO)	11.49	11.48	11.35	11.24	11.26	11.18	10.96	10.88	10.70	10.63
Days Payable Outstanding (DPO)	99.41	34.96	96.62	97.96	93.17	32.11	87.90	94.46	90.62	30.24
Cash Conversion Cycle (CCC)	-37.34	27.79	-34.35	-34.63	-28.08	33.46	-23.01	-31.81	-27.26	31.30
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,931	11,087	11,147	11,158	11,342	11,012	11,435	11,351	11,615	11,548
Invested Capital Turnover	1.27	1.25	1.26	1.26	1.26	1.29	1.30	1.33	1.34	1.40
Increase / (Decrease) in Invested Capital	994	799	681	416	410	-75	288	194	273	535
Enterprise Value (EV)	11,449	15,111	20,068	16,085	13,961	15,208	17,620	17,243	20,287	16,687
Market Capitalization	6,373	9,961	8,922	11,015	8,685	10,362	12,441	12,377	15,278	11,836
Book Value per Share	$80.24	$82.91	$0.00	$86.73	$87.40	$90.08	$93.10	$96.90	$99.02	$101.06
Tangible Book Value per Share	$27.15	$28.16	($55.38)	$30.74	$31.02	$32.47	$34.65	$38.00	$39.58	$41.44
Total Capital	11,006	11,174	11,257	11,237	11,422	11,114	11,547	11,480	11,721	11,644
Total Debt	5,097	5,204	5,200	5,104	5,311	4,912	5,236	4,924	5,034	4,881
Total Long-Term Debt	5,031	5,122	5,104	4,993	5,185	4,786	5,109	4,796	4,996	4,841
Net Debt	5,023	5,101	5,090	5,025	5,230	4,793	5,124	4,795	4,928	4,755
Capital Expenditures (CapEx)	162	164	169	168	200	206	209	241	248	246
Debt-free, Cash-free Net Working Capital (DFCFNWC)	509	602	682	621	809	805	811	590	723	520
Debt-free Net Working Capital (DFNWC)	584	704	792	701	890	925	923	719	829	646
Net Working Capital (NWC)	517	623	696	589	763	798	796	591	791	606
Net Nonoperating Expense (NNE)	31	30	49	42	49	39	42	42	33	26
Net Nonoperating Obligations (NNO)	5,023	5,117	5,090	5,025	5,230	4,810	5,124	4,795	4,928	4,785
Total Depreciation and Amortization (D&A)	146	148	142	144	137	145	141	147	150	147
Debt-free, Cash-free Net Working Capital to Revenue	3.85%	4.49%	5.02%	4.50%	5.77%	5.64%	5.53%	3.93%	4.69%	3.29%
Debt-free Net Working Capital to Revenue	4.41%	5.26%	5.83%	5.08%	6.34%	6.47%	6.30%	4.79%	5.38%	4.08%
Net Working Capital to Revenue	3.91%	4.65%	5.13%	4.27%	5.44%	5.59%	5.43%	3.94%	5.13%	3.83%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.52	$2.44	$2.31	$2.44	$2.42	$3.18	$3.90	$4.32	$3.89	$5.05
Adjusted Weighted Average Basic Shares Outstanding	72.60M	73.12M	70.54M	70.07M	68.87M	69.32M	67.20M	66.88M	66.54M	66.55M
Adjusted Diluted Earnings per Share	$2.50	$2.42	$2.28	$2.42	$2.40	$3.13	$3.82	$4.26	$3.80	$4.94
Adjusted Weighted Average Diluted Shares Outstanding	73.06M	73.83M	71.49M	70.84M	69.62M	70.13M	68.48M	67.92M	68.11M	67.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	71.41M	70.67M	70.18M	69.39M	68.26M	67.22M	66.93M	66.71M	65.97M	65.00M
Normalized Net Operating Profit after Tax (NOPAT)	208	200	211	211	217	259	307	336	299	363
Normalized NOPAT Margin	6.24%	5.81%	6.10%	5.95%	6.10%	6.99%	8.00%	8.60%	7.55%	8.83%
Pre Tax Income Margin	7.02%	6.45%	6.17%	6.33%	6.19%	7.59%	8.74%	9.78%	8.62%	10.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.57	6.07	5.21	5.60	5.13	6.25	7.36	8.81	8.65	12.03
NOPAT to Interest Expense	5.84	4.56	4.15	4.32	4.07	4.83	5.82	6.88	6.70	9.15
EBIT Less CapEx to Interest Expense	3.04	2.32	1.89	2.16	1.38	2.39	3.41	3.88	3.10	5.84
NOPAT Less CapEx to Interest Expense	1.31	0.82	0.84	0.88	0.33	0.98	1.87	1.94	1.15	2.96
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	16.03%	17.10%	16.34%	16.01%	9.02%	8.28%	7.22%	5.70%	4.77%	4.03%
Augmented Payout Ratio	178.91%	143.88%	99.00%	86.34%	82.88%	84.37%	80.68%	66.43%	60.48%	61.70%

Frequently Asked Questions About Universal Health Services' Financials

When does Universal Health Services's fiscal year end?

According to the most recent income statement we have on file, Universal Health Services' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Universal Health Services' net income changed over the last 9 years?

Universal Health Services' net income appears to be on an upward trend, with a most recent value of $1.16 billion in 2024, rising from $750.70 million in 2015. The previous period was $719.31 million in 2023. View Universal Health Services' forecast to see where analysts expect Universal Health Services to go next.

What is Universal Health Services's operating income?

Universal Health Services's total operating income in 2024 was $1.68 billion, based on the following breakdown:

Total Gross Profit: $8.31 billion
Total Operating Expenses: $6.63 billion

How has Universal Health Services revenue changed over the last 9 years?

Over the last 9 years, Universal Health Services' total revenue changed from $9.04 billion in 2015 to $15.83 billion in 2024, a change of 75.0%.

How much debt does Universal Health Services have?

Universal Health Services' total liabilities were at $7.71 billion at the end of 2024, a 0.8% decrease from 2023, and a 52.2% increase since 2015.

How much cash does Universal Health Services have?

In the past 9 years, Universal Health Services' cash and equivalents has ranged from $33.75 million in 2016 to $1.22 billion in 2020, and is currently $125.98 million as of their latest financial filing in 2024.

How has Universal Health Services' book value per share changed over the last 9 years?

Over the last 9 years, Universal Health Services' book value per share changed from 43.16 in 2015 to 101.06 in 2024, a change of 134.2%.

Related Companies

This page (NYSE:UHS) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Universal Health Services (UHS) Financials

Frequently Asked Questions About Universal Health Services' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Universal Health Services (UHS) Financials

Annual Income Statements for Universal Health Services

Quarterly Income Statements for Universal Health Services

Annual Cash Flow Statements for Universal Health Services

Quarterly Cash Flow Statements for Universal Health Services

Annual Balance Sheets for Universal Health Services

Quarterly Balance Sheets for Universal Health Services

Annual Metrics and Ratios for Universal Health Services

Quarterly Metrics and Ratios for Universal Health Services

Frequently Asked Questions About Universal Health Services' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools